AAMA Global Healthcare Conference “AI: The Next Digital Frontier for Healthcare Innovation”

Innovations in the technology sector and overall global development are coming together right now, bringing unprecedented growth and improvement to the healthcare and biotechnology sectors. Chief among the advances fueling this growth is artificial intelligence, or AI.

On January 13, 2020, AAMA is hosting its Global Healthcare Conference in San Francisco, held in conjunction with the industry’s biggest healthcare symposium, J.P Morgan’s Healthcare Conference. The AAMA Global Healthcare Conference “AI: The Next Digital Frontier for Healthcare Innovation” is bringing together recognized industry leaders, top global researchers and medical professionals, entrepreneurs, investors, and innovators from Silicon Valley and Asia to discuss the impacts of AI on biotechnology and healthcare.

Attendees of the AAMA Global Healthcare Conference will learn about highly relevant topics:

• Data-driven technologies’ impact on healthcare
• Creative strategies for technology teams
• Effects of new technology on patients’ and providers’ daily lives
• Key points to build to attract investors looking to expand healthtech innovations

AAMA’s Global Healthcare Conference will focus on healthcare and provide attendees the opportunity to learn more about AI’s impact through keynote talks, panel discussions, showcases, and exhibitors. Expect to build network connections during lunch, coffee chats, and the closing reception.

Seating is limited at this exclusive conference, so register to reserve your spot today! The movers and shakers of the industry will be present on January 13, 2020 to discuss investment in healthcare and data-driven technology trends that are revolutionizing the industry. You do not want to miss out!

CONFIRMED SPEAKERS:

Atul Butte, MD, PhD

Priscilla Chan and Mark Zuckerberg

Distinguished Professor

Director, Bakar Computational Health Sciences Institute (bakarinstitute.ucsf.edu)

University of California, San Francisco

Chief Data Scientist

Carmen Chang

General Partner; Chairman and Head, Asia, Menlo Park & China

NEA

NEA focuses investment stages ranging from seed stage through growth stage across an array of industry sectors. With over $20 billion in assets under management, NEA was the world’s largest venture capital firm in 2007.

BIO

Rebecca Stevenson

Managing Director, Head of Life Sciences

Wells Fargo

BIO

Robert S. Warren, MD

Professor of Surgery

UCSF

Co-Founder

MORE Health

MORE Health delivers access to the best physicians in the world through its cloud-based medical collaboration platform.

BIO

Jerry Iwata

Director, Life Sciences Group

Wells Fargo

BIO

Professor W. John Kao

Head, BioMedical Cluster

Hong Kong Science and Technology Parks Corporation

HKSTP is a public corporation set up by the Hong Kong Government in 2001 to foster the development of innovation and technology in Hong Kong.

BIO

Andrew A. Radin

CEO and Co-Founder

twoXAR, Inc.

twoXAR is a biopharmaceutical company that uses AI to identify and develop new medicines.

BIO

Aswin Gunasekar, MS, MBA

CEO & Founder

Zeto

Zeto provides convenient device platforms for better diagnosis and management of life-changing conditions.

Iris S. Chan

Founder and CEO

Ameriway Inc.

Ameriway focuses on early-stage investments and cross-border trades between North America and Asia.

BIO

Junbao Shan

CEO and Member of Board of Directors

CICC Zhide Capital

CICC Zhide Capital is a wholly-owned private equity subsidiary of CICC

John Sun

Managing Partner/Head of TMT Investment

New Horizon Capital

New Horizon Capital is a private equity firm investing in growth and expansion stage companies in China.

BIO

Lei Xing

Jack Haimson Professor of Medical Physics and

Director of Medical Physics Division of Radiation Oncology Department

Edwin McCarthy

Vice President, Center for International Medicine

City of Hope National Medical Center

BIO

Carrie Hurwitz Williams

Principal

McKesson Ventures

McKesson Ventures is a strategic venture firm backed by McKesson Corporation focusing on early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. health care landscape.

BIO

Michael Chan

Head of International Issuer Business

Hong Kong Exchanges and Clearing Limited (HKEx)

HKEX is a stock exchange based in Hong Kong. It is Asia’s third-largest in terms of market capitalization behind the Tokyo Stock Exchange and Shanghai Stock Exchange, and the fourth single largest stock market in the world.

BIO

Mary Jo Potter

CEO and Managing Director

Healthcare Angels

General Partner

Keiretsu Capital

BIO

Xiaodong Jiang

Managing Partner

Long Hill Capital

Long Hill Capital is a leading venture capital firm investing in high-growth technology and healthcare companies in China.

BIO

Randy Williams

Founder and CEO

Keiretsu Forum

Keiretsu Forum is a global angel investor network with more than 2500 accredited investor members throughout 47 chapters on 3 continents.

BIO

George Ugras

Managing Partner

AV8 Ventures

AV8 Ventures is a $180mil early-stage Palo Alto and London based venture capital firm aiming to partner with visionary entrepreneurs who are changing the future in data-driven health, mobility and intelligent enterprise.

BIO

Brian A. Smith

Founder/CEO

RedCrow – Equity Crowdfunding

RedCrow connects financial and human capital to healthcare start-ups.

BIO

John Huber

National Sales Executive, Technology Banking Group

Wells Fargo

BIO

Lisa M. Lum

Executive Director

AAMA Silicon Valley

***STAY TUNED FOR SPEAKER UPDATES!***

AGENDA AT A GLANCE

9:00am-9:30am: Registration

9:30am-10:00am: Opening Keynote, plus Q&A

• Atul Butte, MD, PhD
• Priscilla Chan and Mark Zuckerberg Distinguished Professor
• Director, Bakar Computational Health Sciences Institute (bakarinstitute.ucsf.edu)
• University of California, San Francisco
• Chief Data Scientist, University of California Health (UC Health)

10:00am-10:50am: Panel Discussion: Every Healthcare Professionals Dream: AI in Data, Diagnosis and Patient Care

• Moderator: Jerry Iwata, Director – Life Sciences Group, Wells Fargo
• Aashima Gupta, Director, Global Healthcare Solutions, Google Cloud
• Aswin Gunasekar, CEO, Zeto
• Adam Hanina, CEO, AiCure
• Professor W. John Kao, Head, BioMedical Cluster, Hong Kong Science and Technology Parks Corporation
• Andrew Radin, CEO and Co-founder, twoXAR

10:50am-11:15am: AI Product Launch by MORE Health

11:15am-12:00pm: Keynote Fireside Chat

• Moderator: John Sun, Managing Partner/Head of TMT Investment, New Horizon Capital
• Iris S. Chan, Founder and CEO, Ameriway Inc.
• Junbao Shan, CEO and Member of Board of Directors, CICC Zhide Capital, a wholly-owned private equity subsidiary of CICC
• James Zhang, Chief Strategy Officer, Centrillion Technologies

12:00pm-12:45pm: Lunch

12:45pm-1:05pm: Keynote Presentation

• Lloyd B. Minor, MD., Carl and Elizabeth Naumann Professor for the Dean of the School of Medicine, Stanford University

1:05pm-1:50pm: Panel Discussion: Provider Perspectives on the Future of Healthcare

• Moderator: Rebecca Stevenson, Managing Director, Head of Life Sciences, Wells Fargo
• Robert S. Warren, MD, Co-founder, MORE Health
• Edwin McCarthy, Vice President, Center for International Medicine, City of Hope National Medical Center
• Mark A. Davis, MD, MS, Vice President of Business Development and Medical Affairs for Brigham Health International; Executive Director of Business Development and Strategic Initiatives for Brigham and Women’s Hospital
• Lei Xing, Jack Haimson Professor of Medical Physics and Director of Medical Physics Division of Radiation Oncology Department, Stanford University

1:50pm-2:10pm: Keynote Presentation

• Chris Knackstedt, Founder, ValueIQ, LLC.; Founder, Tellus Wellness

2:10pm-2:55pm: Panel Discussion: Emerging Trends and Innovations in Biopharma

• Pierre R. Theodore, MD, Vice President Global External Innovation, Johnson & Johnson Innovation

2:55pm-3:05pm: Coffee Break

3:05pm-3:25pm: Keynote Fireside Chat

• Moderator: Jerry Iwata, Director – Life Sciences Group, Wells Fargo
• Carrie Hurwitz Williams, Principal, McKesson Ventures

3:25pm-3:45pm: Keynote Presentation

• Michael Chan, Head of International Issuer Business, Hong Kong Exchanges and Clearing Limited, HKEx

3:45pm-4:30pm: Panel Discussion: Venture Capital Investing in Silicon Valley and Asia: Healthcare Predictions for 2020 and Beyond

• Moderator: Mary Jo Potter, Healthcare Angels
• Carmen Chang, General Partner, Head, Asia, Menlo Park & China, NEA
• Xiaodong Jiang, Managing Partner, Long Hill Capital
• Brian A. Smith, Founder/CEO, RedCrow
• George Ugras, Managing Director, AV8 Ventures
• Randy Williams, CEO, Keiretsu Forum

4:30pm-5:25pm: Company Presentations by Top Innovators in Life Sciences and Healthcare Sectors

• 9th Gear – Same-Day FX & On-Demand Payment Liquidity.
• Avive – Developer of next generation Automated External Defibrillator (AED).
• iDentical – Developer of personalized dentail implants.
• Health Hero – Modern Health Engagement.
• Otonexus – Commercializing a ground-breaking ultrasound medical device to rapidly and accurately diagnose middle ear infections.

5:25pm-5:30pm: Remarks by Ivanhoe Chang, Director, Hong Kong Economic and Trade Office, San Francisco

5:30pm-7:00pm: Networking Reception sponsored by HKETO

7:00pm: Event Concludes

*Stay tuned for program updates!

THANK YOU TO OUR SPONSORS:

PLATINUM + VENUE SPONSOR:

PLATINUM SPONSOR:

GOLD + NETWORKING RECEPTION SPONSOR:

Details on 2020’s exhibitors are forthcoming—stay tuned! If you are interested in joining us to showcase your company in 2020, contact us soon, before the remaining slots are filled.

For sponsorship, speaker, exhibitor opportunities, please contact hello@aamasv.com

***

General Information:

Wells Fargo

333 Market Street (Valet Parking Entrance – 33 Fremont Street, San Francisco, CA 94103)

Valet Parking available Mon-Fri from 6am-7pm